Guggenheim starts Equinix with Buy, sees ‘attractive' opportunity
Don't Miss TipRanks' Half-Year Sale
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Datadog, Inc. (DDOG) Is Competing With The Rise Of AI, Says Jim Cramer
We recently published . Datadog, Inc. (NASDAQ:DDOG) is one of the stocks Jim Cramer recently discussed. Datadog, Inc. (NASDAQ:DDOG) is a software company that works primarily with cloud computing providers and users. The firm's products allow customers to monitor their platforms in real-time. Datadog, Inc. (NASDAQ:DDOG)'s shares have lost 4% year-to-date, primarily on the back of an 11% dip in July. The shares have lost ground this month because of a downgrade from Guggenheim, which reduced the rating to Sell from Neutral and set a $105 share price target for the company. Cramer discussed how AI has harmed Datadog, Inc. (NASDAQ:DDOG): '[On Morgan Stanley saying Tim Cook's successor could benefit from having a hardware background] Well look, it's funny hardware is part of the, I'm glad you mentioned hardware, hardware's part of the issue of how NVIDIA got to where it is. This is an essentially, there's a belief in many people on Wall Street and in Silicon Valley, that hardware prevails here because we're gonna get rid of a huge number of people who would do SaaS, you know, software as a service, and that includes, yes, Salesforce, includes ServiceNow, includes DataDog which got out of the S&P. Because there are going to be fewer and fewer people who are actually in the organization who need that.' A close-up of a laptop with a software engineer coding on the monitor. Baron Funds mentioned Datadog, Inc. (NASDAQ:DDOG) in its Q1 2025 investor letter. Here is what the fund said: 'Most of our companies do not sell goods but instead provide critical services to their Inc. (NASDAQ:DDOG), the leading cloud-based observability platform, has seen its stock decline by over 30% year-to-date because its revenues are based on consumption/usage and would likely be impacted by any significant cyclical downturn. However, its competitive position has gotten stronger, its market share is continuing to rise, and it is indexed to promising long-term secular trends of cloud adoption and accelerating app development, and is well positioned for AI as the critical central IT infrastructure platform for its customers.' While we acknowledge the potential of DDOG as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
an hour ago
- Business Insider
Amgen (AMGN) Gets a Buy from Bernstein
In a report released on July 8, Courtney Breen from Bernstein maintained a Buy rating on Amgen, with a price target of $350.00. The company's shares closed yesterday at $295.27. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Breen covers the Healthcare sector, focusing on stocks such as Eli Lilly & Co, Merck & Company, and Moderna. According to TipRanks, Breen has an average return of 2.7% and a 50.00% success rate on recommended stocks. In addition to Bernstein, Amgen also received a Buy from BMO Capital's Evan Seigerman in a report issued on July 9. However, on July 10, Morgan Stanley maintained a Hold rating on Amgen (NASDAQ: AMGN).
Business Insider
an hour ago
- Business Insider
Aberdeen Group (ABDN) Receives a Buy from Goldman Sachs
In a report released on July 8, Oliver Carruthers from Goldman Sachs reiterated a Buy rating on Aberdeen Group, with a price target of p215.00. The company's shares closed yesterday at p192.30. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Carruthers covers the Financial sector, focusing on stocks such as Aberdeen Group, flatexDEGIRO AG, and DWS Group GmbH & Co KGaA. According to TipRanks, Carruthers has an average return of 3.1% and a 54.95% success rate on recommended stocks. In addition to Goldman Sachs, Aberdeen Group also received a Buy from J.P. Morgan's Enrico Bolzoni in a report issued on July 7. However, on July 10, RBC Capital maintained a Sell rating on Aberdeen Group (LSE: ABDN). Based on Aberdeen Group's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of p732 million and a net profit of p72 million. In comparison, last year the company earned a revenue of p711 million and had a net profit of p152 million
